Home › Prostate Cancer › New Hampshire
Prostate Cancer clinical trials in New Hampshire
7 studies for Prostate Cancer are looking for participants at sites in New Hampshire.
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- New Hampshire Oncology Hematology PA-Concord, Concord
- Solinsky Center for Cancer Care, Manchester
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
- Dartmouth-Hitchcock Medical Center, Lebanon
RecruitingPhase 2
Ages 18 and older · Men · Updated Sep 14, 2026 · NCT06111781Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 10, 2026 · NCT05946213Telmisartan in Prostate Cancer
- Dartmouth Health, Lebanon
RecruitingPhase 1
Ages 18 and older · Men · Updated Jul 22, 2026 · NCT06168487Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon
RecruitingPhase 3
Ages 18 and older · Men · Updated Jul 14, 2026 · NCT06592924Microendoscopic EI Sensing for Real-time Intraoperative Surgical Margin Assessment
- Dartmouth-Hitchcock Medical Center, Lebanon
RecruitingObservational study
Ages 18 and older · Men · Updated Apr 7, 2026 · NCT06039085Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- New Hampshire Oncology Hematology PA-Concord, Concord
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon
- Solinsky Center for Cancer Care, Manchester
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 11, 2025 · NCT03678025From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.